ネバダ州におけるがん（全種類）の臨床試験
ネバダ州内の拠点で、がん（全種類）に関する13件の研究が参加者を募集しています。
ネバダ州内の都市
公式研究テキスト（英語）
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
- Comprehensive Cancer Centers of Nevada ( Site 1109), Las Vegas
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07209111A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Renown Health Medical Oncology, Reno
- Renown Office of Clinical Research, Reno
- Renown Regional Medical Center, Reno
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06989437A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
- Research Site, Reno
被験者募集中第3相
18歳〜130歳 · 全性別 · 2026/09/08更新 · NCT07647328A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Comprehensive Cancer Centers of Nevada, Las Vegas
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581Project: Every Child for Younger Patients With Cancer
- Oncology Las Vegas - Henderson, Henderson
- University Medical Center of Southern Nevada, Las Vegas
- Sunrise Hospital and Medical Center, Las Vegas
- 他5件
被験者募集中観察研究
25歳以下 · 全性別 · 2026/08/25更新 · NCT02402244Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Women's Cancer Center of Nevada, Las Vegas
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/07更新 · NCT06580314A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- Comprehensive Cancer Center of Nevada, Las Vegas
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/15更新 · NCT06657144A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- Renown Regional Medical Center /ID# 276049, Reno
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/06/08更新 · NCT07005102Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
- Comprehensive Cancer Center of Nevada, Las Vegas
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/03/02更新 · NCT06014658TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
- Cancer Care Specialists - Reno, Reno
被験者募集中観察研究
18歳〜99歳 · 全性別 · 2026/02/24更新 · NCT06207032GEMINI-NSCLC: NSCLC Biomarker Study
- OptumCare Cancer Care, Las Vegas
- Hope Cancer Care of Nevada, Las Vegas
- Cancer Care Specialists Reno, Reno
被験者募集中観察研究
18歳以上 · 全性別 · 2026/02/05更新 · NCT05236114Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
- Women's Cancer Center of Nevada, Las Vegas
被験者募集中第2相
18歳以上 · 全性別 · 2025/11/13更新 · NCT05997017Prospective Study of oncRNA Stratification of Cancer by Size and Stage
- Renown Health, Reno
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2025/03/18更新 · NCT05833360ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。